{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-21-067912","form_type":"8-K","ticker":"CPHI","cik":"0001106644","company_name":"CHINA PHARMA HOLDINGS, INC.","filed_at":"2021-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.516203+00:00","generated_at":"2026-06-27T21:52:00.378976+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Annual meeting elects five directors, approves incentive plan amendment","bullets":["Quorum of 55% (35,348,061 shares) present at Dec 26, 2021 annual meeting.","All five director nominees elected: Zhilin Li, Heung Mei Tsui, Gene Michael Bennett, Yingwen Zhang, Baowen Dong.","Amendment No.2 to 2010 Long-Term Incentive Plan approved (25,917,951 for, 94,918 against, 7,791 abstentions)."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-21-067912","json":"https://secwatch.observer/filing/0001213900-21-067912.json","markdown":"https://secwatch.observer/filing/0001213900-21-067912.md","text":"https://secwatch.observer/filing/0001213900-21-067912.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1106644/000121390021067912/0001213900-21-067912-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1106644/000121390021067912/ea153163-8k_chinapharma.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T21:52:00.378976+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}